KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Cash from Investing Activities (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Cash from Investing Activities for 17 consecutive years, with -$913.0 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 5.43% to -$913.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.4 billion through Dec 2025, down 3.59% year-over-year, with the annual reading at -$2.4 billion for FY2025, 3.59% down from the prior year.
  • Cash from Investing Activities hit -$913.0 million in Q4 2025 for Abbott Laboratories, down from -$457.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$264.0 million in Q2 2021 to a low of -$1.2 billion in Q2 2023.
  • Historically, Cash from Investing Activities has averaged -$582.0 million across 5 years, with a median of -$533.0 million in 2022.
  • Biggest five-year swings in Cash from Investing Activities: crashed 359.47% in 2023 and later soared 62.65% in 2024.
  • Year by year, Cash from Investing Activities stood at -$671.0 million in 2021, then increased by 5.81% to -$632.0 million in 2022, then crashed by 30.38% to -$824.0 million in 2023, then fell by 5.1% to -$866.0 million in 2024, then dropped by 5.43% to -$913.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for ABT at -$913.0 million in Q4 2025, -$457.0 million in Q3 2025, and -$582.0 million in Q2 2025.